Factors | Category | Univariate P value* | Multivariate | |
---|---|---|---|---|
HR (95% CI) | P value** | |||
Age (years) |  < 71 vs. ≥ 71 | 0.22 |  |  |
Sex | Male vs. Female | 0.97 | Â | Â |
Etiology | HBV plus HCV vs. others | 0.74 | Â | Â |
Albumin (g/dL) |  < 3.5 vs. ≥ 3.5 | 0.15 |  |  |
Total bilirubin (mg/dL) |  < 1.0 vs. ≥ 1.0 | 0.16 |  |  |
Prothrombin activity (%) |  < 81 vs. ≥ 81 | 0.97 |  |  |
Aspartate aminotransferase (IU/L) |  < 37 vs. ≥ 37 | 0.04 | 3.09 (1.01–9.47) | 0.04 |
Alanine aminotransferase (IU/L) |  < 25 vs. ≥ 25 | 0.06 |  |  |
γ-Glutamyl transpeptidase (IU/L) |  < 64 vs. ≥ 64 | 0.10 |  |  |
Platelet count (× 103/µL) |  < 102 vs. ≥ 102 | 0.74 |  |  |
Ammonia (µg/dL) |  < 55 vs. ≥ 55 | 0.05 |  |  |
Child–Pugh class | A vs. B or C | 0.26 |  |  |
Fib-4 index |  < 4.80 vs. ≥ 4.80 | 0.58 |  |  |
Presence of splenomegaly | Yes vs. no | 0.58 | Â | Â |
Gastric varices bleeding | Yes vs. no | 0.69 | Â | Â |
Co-existence of esophageal varices | Yes vs. no | 0.50 | Â | Â |
History of hepatocellular carcinoma | Yes vs. no | 0.88 | Â | Â |
Diameter of LGV before BRTO |  < 5 vs. ≥ 5 | 0.40 |  |  |
Liver stiffness measurement (kPa) |  < 30.2 vs. ≥ 30.2 | 0.01 |  |  |
Pre-HVPG (mmHg) |  < 13 vs. ≥ 13 | 0.06 |  |  |
Post-HVPG (mmHg) |  < 13 vs. ≥ 13 | 0.03 | 3.04 (1.25–7.38) | 0.01 |